Thornburg Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q2 | – | Sell |
-3,335,555
| Closed | -$52.3M | – | 186 |
|
2019
Q1 | $52.3M | Sell |
3,335,555
-203,966
| -6% | -$3.2M | 0.51% | 56 |
|
2018
Q4 | $54.6M | Sell |
3,539,521
-488,671
| -12% | -$7.54M | 0.53% | 50 |
|
2018
Q3 | $86.8M | Buy |
4,028,192
+202,777
| +5% | +$4.37M | 0.72% | 40 |
|
2018
Q2 | $93M | Buy |
3,825,415
+16,888
| +0.4% | +$411K | 0.71% | 38 |
|
2018
Q1 | $65.1M | Buy |
3,808,527
+1,032,302
| +37% | +$17.6M | 0.49% | 48 |
|
2017
Q4 | $52.6M | Buy |
2,776,225
+1,706,406
| +160% | +$32.3M | 0.37% | 62 |
|
2017
Q3 | $18.8M | Sell |
1,069,819
-3,236,898
| -75% | -$57M | 0.13% | 133 |
|
2017
Q2 | $143M | Buy |
+4,306,717
| New | +$143M | 1.09% | 27 |
|
2013
Q4 | – | Sell |
-1,541,558
| Closed | -$58.2M | – | 293 |
|
2013
Q3 | $58.2M | Buy |
1,541,558
+25,725
| +2% | +$972K | 0.23% | 112 |
|
2013
Q2 | $59.4M | Buy |
+1,515,833
| New | +$59.4M | 0.27% | 103 |
|